BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 26055490)

  • 21. A 10-year experience of liver transplantation for hepatitis C: analysis of factors determining outcome in over 500 patients.
    Ghobrial RM; Steadman R; Gornbein J; Lassman C; Holt CD; Chen P; Farmer DG; Yersiz H; Danino N; Collisson E; Baquarizo A; Han SS; Saab S; Goldstein LI; Donovan JA; Esrason K; Busuttil RW
    Ann Surg; 2001 Sep; 234(3):384-93; discussion 393-4. PubMed ID: 11524591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Donor risk factors in orthotopic liver transplant: analysis of the OPTN/UNOS registry.
    Kawakita S; Everly MJ
    Clin Transpl; 2013; ():13-22. PubMed ID: 25095488
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Donor age affects fibrosis progression and graft survival after liver transplantation for hepatitis C.
    Machicao VI; Bonatti H; Krishna M; Aqel BA; Lukens FJ; Nguyen JH; Rosser BG; Satyanarayana R; Grewal HP; Hewitt WR; Harnois DM; Crook JE; Steers JL; Dickson RC
    Transplantation; 2004 Jan; 77(1):84-92. PubMed ID: 14724440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liver transplantation and hepatitis C virus. Results in a Spanish center since 1989.
    Loinaz C; Lumbreras C; Moreno E; Colina F; Fuertes A; Gómez R; Jiménez C; González-Pinto I; García I; Rojas J; Bellorín C
    Hepatogastroenterology; 2001; 48(41):1435-42. PubMed ID: 11677981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of the donor risk index on the outcome of hepatitis C virus-positive liver transplant recipients.
    Maluf DG; Edwards EB; Stravitz RT; Kauffman HM
    Liver Transpl; 2009 Jun; 15(6):592-9. PubMed ID: 19479802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recipient characteristics and morbidity and mortality after liver transplantation.
    Asrani SK; Saracino G; O'Leary JG; Gonzalez S; Kim PT; McKenna GJ; Klintmalm G; Trotter J
    J Hepatol; 2018 Jul; 69(1):43-50. PubMed ID: 29454069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Post-transplant outcomes of patients with and without hepatitis C virus infection according to donor age and gender matching.
    Grąt M; Kornasiewicz O; Lewandowski Z; Ligocka J; Grąt K; Wronka KM; Zieniewicz K; Krawczyk M
    Ann Transplant; 2013 Dec; 18():705-15. PubMed ID: 24361968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Positive serum cryoglobulin is associated with worse outcome after liver transplantation for chronic hepatitis C.
    Rayhill SC; Kirby PA; Voigt MD; La Brecque DR; Lutz CT; Katz DA; Mitros FA; Kalil RS; Miller RA; Stolpen AH; Heisey D; Wu YM; Schmidt WN
    Transplantation; 2005 Aug; 80(4):448-56. PubMed ID: 16123717
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimizing repeat liver transplant graft utility through strategic matching of donor and recipient characteristics.
    Hung K; Gralla J; Dodge JL; Bambha KM; Dirchwolf M; Rosen HR; Biggins SW
    Liver Transpl; 2015 Nov; 21(11):1365-73. PubMed ID: 25865434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcomes of liver transplantation from hepatitis B core antibody-positive donors in viral cirrhosis patients: the prevailing negative effect of recipient hepatitis C virus infection.
    Tandoi F; Romagnoli R; Martini S; Mazza E; Nada E; Cocchis D; Lupo F; Salizzoni M
    Transplant Proc; 2012 Sep; 44(7):1963-5. PubMed ID: 22974883
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of hepatitis C virus viremia on renal graft and patient survival: a 9-year prospective study.
    Mahmoud IM; Elhabashi AF; Elsawy E; El-Husseini AA; Sheha GE; Sobh MA
    Am J Kidney Dis; 2004 Jan; 43(1):131-9. PubMed ID: 14712436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of Donor Recipient Gender and Race Mismatch on Graft Outcomes in Patients With End-Stage Liver Disease Undergoing Liver Transplantation.
    Zhang Y
    Prog Transplant; 2017 Mar; 27(1):39-47. PubMed ID: 27895103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of hepatitis C virus donor and recipient status on long-term kidney transplant outcomes: University of Wisconsin experience.
    Singh N; Neidlinger N; Djamali A; Leverson G; Voss B; Sollinger HW; Pirsch JD
    Clin Transplant; 2012; 26(5):684-93. PubMed ID: 22283142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of liver grafts from donation after cardiac death donors for recipients with hepatitis C virus.
    Taner CB; Bulatao IG; Keaveny AP; Willingham DL; Pungpapong S; Perry DK; Rosser BG; Harnois DM; Aranda-Michel J; Nguyen JH
    Liver Transpl; 2011 Jun; 17(6):641-9. PubMed ID: 21618684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liver transplantation in the MELD era--analysis of the OPTN/UNOS registry.
    Taniguchi M
    Clin Transpl; 2012; ():41-65. PubMed ID: 23721009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Female donor to male recipient gender discordance results in inferior graft survival: a prospective study of 1,042 liver transplants.
    Croome KP; Segal D; Hernandez-Alejandro R; Adams PC; Thomson A; Chandok N
    J Hepatobiliary Pancreat Sci; 2014 Apr; 21(4):269-74. PubMed ID: 24123790
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analyzing predictors of graft survival in patients undergoing liver transplantation with donors aged 70 years and over.
    Caso-Maestro O; Jiménez-Romero C; Justo-Alonso I; Calvo-Pulido J; Lora-Pablos D; Marcacuzco-Quinto A; Cambra-Molero F; García-Sesma A; Pérez-Flecha M; Muñoz-Arce C; Loinaz-Segurola C; Manrique-Municio A
    World J Gastroenterol; 2018 Dec; 24(47):5391-5402. PubMed ID: 30598583
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The corrected donor age for hepatitis C virus-infected liver transplant recipients.
    Dirchwolf M; Dodge JL; Gralla J; Bambha KM; Nydam T; Hung KW; Rosen HR; Feng S; Terrault NA; Biggins SW
    Liver Transpl; 2015 Aug; 21(8):1022-30. PubMed ID: 26074140
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching.
    Angelico M; Cillo U; Fagiuoli S; Gasbarrini A; Gavrila C; Marianelli T; Costa AN; Nardi A; Strazzabosco M; Burra P; Agnes S; Baccarani U; Calise F; Colledan M; Cuomo O; De Carlis L; Donataccio M; Ettorre GM; Gerunda GE; Gridelli B; Lupo L; Mazzaferro V; Pinna A; Risaliti A; Salizzoni M; Tisone G; Valente U; Rossi G; Rossi M; Zamboni F;
    Dig Liver Dis; 2011 Feb; 43(2):155-64. PubMed ID: 21185796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis B-core antibody positive donors in liver transplantation and their impact on graft survival: evidence from the Liver Match cohort study.
    Angelico M; Nardi A; Marianelli T; Caccamo L; Romagnoli R; Tisone G; Pinna AD; Avolio AW; Fagiuoli S; Burra P; Strazzabosco M; Costa AN;
    J Hepatol; 2013 Apr; 58(4):715-23. PubMed ID: 23201239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.